Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Novartis begins shipment of influenza vaccine

Novartis begins shipment of influenza vaccine

8th August 2008

Novartis has announced it has begun its shipment of its Fluvirin influenza virus vaccine for the 2008-9 ‘flu season with three new strains.

For the upcoming year, the vaccine contains the A/Brisbane/59/2007 (H1N1)-like virus, A/Brisbane/10/2007 (H3N2)-like virus and the B/Florida/4/2006-like virus.

The company is delivering the vaccine to the US to support the planning and scheduling of public health influenza vaccination efforts.

Novartis claims a minimum of 20 million doses of the vaccine will be available by the end of September, the traditional start of widespread vaccination campaigns for the disease.

The company notes additional manufacturing capacity for pre-filled syringes containing Fluvirin has recently been approved by the US Food and Drug Administration.

Joerg Reinhardt, chief executive officer of vaccines and diagnostics at Novartis, said: “Novartis is committed to delivering high quality influenza vaccine to help protect more people against this potentially serious and contagious disease.”

He added the early provision of large quantities of the vaccine supports public health efforts to vaccinate individuals as soon as possible.

Last year, Novartis announced plans to produce around 40 million doses of Fluvirin in the US over the whole influenza season in 2007-8, a rise of 30 per cent on the previous year.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.